99.23% Topiramate Powder

Topiramate
Molecular Formula:C12H21NO8S
Formula Weight:339.36
CAS No.:97240-79-4
Appearance:white powder
Purity:99.23%

Topiramate is an anticonvulsant (antiepilepsy) drug. In late 2012, topiramate was approved by the United States Food and Drug Administration (FDA) in combination with phentermine for weight loss. The drug had previously been used off-label for this purpose.

Topiramate is used to treat epilepsy in children and adults, and it was originally used as an anticonvulsant.In children, it is indicated for the treatment of Lennox-Gastaut syndrome, a disorder that causes seizures and developmental delay. It is also Food and Drug Administration (FDA) approved for, and most frequently prescribed for, the prevention of migraines.The drug is also used to treat migraines due to the effect it has on the blood vessels in the brain. It has been found to be increasingly effective for migraine sufferers with limited side effects.

99% Acetazolamide Powder

Acetazolamide
Molecular Formula:C4H6N4O3S2
Formula Weight:222.25
CAS No.:59-66-5
Appearance:white powder
Purity:99%

Acetazolamide is a medication used to treat glaucoma, epilepsy, altitude sickness, periodic paralysis, and heart failure.It may be used long term for the treatment of open angle glaucoma and short term for acute angle closure glaucoma until surgery can be carried out.It is taken by mouth or injection into a vein.

 

99% Phenobarbital Powder

Phenobarbital
Molecular Formula:C12H12N2O3
Formula Weight:232.24
CAS No.:50-06-6
Appearance:white powder
Purity:99%

Phenobarbital, also known as phenobarbitone or phenobarb, is a medication recommended by the World Health Organization for the treatment of certain types of epilepsy in developing countries.In the developed world it is commonly used to treat seizures in young children,while other medications are generally used in older children and adults.It may be used intravenously, injected into a muscle, or taken by mouth. The injectable form may be used to treat status epilepticus. Phenobarbital is occasionally used to treat trouble sleeping, anxiety, and drug withdrawal and to help with surgery.It usually begins working within five minutes when used intravenously and half an hour when administered orally.Its effects last for between four hours and two days.

99% Sodium Valproate Powder

sodium valproate
Molecular Formula:C8H15NaO2
Formula Weight:166.19
CAS No.:1069-66-5
Appearance:white powder
Purity:99%

Valproate (VPA), and its valproic acid, sodium valproate, and divalproex sodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches.It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures. It can be given intravenously or by mouth. Long and short acting formulations exist.

It is used primarily to treat epilepsy and bipolar disorder. It is also used to prevent migraine headaches.[

99% Carbamazepine Powder

Carbamazepine
Molecular Formula:C15H12N2O
Formula Weight:236.27
CAS No.:298-46-4
Appearance:white powder
Purity:99%

Carbamazepine (CBZ) is a medication used primarily in the treatment of epilepsy and neuropathic pain.It is not effective for absence seizures or myoclonic seizures. It is used in schizophrenia along with other medications and as a second line agent in bipolar disorder.Carbamazepine appears to work as well as phenytoin and valproate.

Carbamazepine is typically used for the treatment of seizure disorders and neuropathic pain.It is used off-label as a second-line treatment for bipolar disorder and in combination with an antipsychotic in some cases of schizophrenia when treatment with a conventional antipsychotic alone has failed.It is not effective for absence seizures or myoclonic seizures.

The drug is also claimed to be effective for ADHD.

99% Stiripenol Powder to treat epilepsy

Stiripenol
Molecular Formula:C14H18O3
Formula Weight:234.29
CAS No.:49763-96-4
Appearance:white powder
Purity:99%

Stiripentol is an anticonvulsant drug used in the treatment of epilepsy. It is approved for the treatment of Dravet syndrome, an epilepsy syndrome. It is unrelated to other anticonvulsants and belongs to the group of aromatic allylic alcohols.

As with most anticonvulsants, the precise mechanism of action is unknown. Regardless, stiripentol has been shown to have anticonvulsant effects of its own.

Stiripentol increases GABAergic activity. At clinically relevant concentrations, it enhances central GABA neurotransmission through a barbiturate-like effect, since it increases the duration of opening of GABA-A receptor channels in hippocampal slices.It has also been shown to increase GABA levels in brain tissues by interfering with its reuptake and metabolism.Specifically, it has been shown to inhibit lactate dehydrogenase, which is an important enzyme involved in the energy metabolism of neurons. Inhibition of this enzyme can make neurons less prone to fire action potentials, likely through activation of ATP-sensitive potassium channels.

Stiripentol also improves the effectiveness of many other anticonvulsants, possibly due to its inhibition of certain enzymes, slowing the drugs’ metabolism and increasing blood plasma levels.

99% Retigabine Dihydrochloride Powder

Retigabine Dihydrochloride
Molecular Formula:C16H20Cl2FN3O2
Formula Weight:339.79
CAS No.:150812-13-8
Appearance:white powder
Purity:99%

99% Lacosamide Powder

Lacosamide
Molecular Formula:C13H18N2O3
Formula Weight:250.29
CAS No.:175481-36-4
Appearance:white powder
Purity:99%

Lacosamide is a medication discovered by Dr. Harold Kohn and Dr. Shridhar Andurkar while at the University of Houston and developed by Union Chimique Belge (UCB) for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain

99% Levetiracetam Raw Powder

Molecular Formula:C8H14N2O2
Formula Weight:170.21
CAS No.:102767-28-2;51052-62-1
Appearance:white powder
Purity:99%

Levetiracetam is a medication used to treat epilepsy.[1] It is used for partial onset, myoclonic, or tonic-clonic seizures. It is the S-enantiomer of etiracetam.

Levetiracetam has been approved in the United States as add-on treatment for partial (focal), myoclonic, and tonic-clonic seizures.Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case of partial seizures, or as an adjunctive therapy for partial, myoclonic, and tonic-clonic seizures.Levetiracetam has been shown to reduce partial (focal) seizures by 50% or more as an add-on medication.It is also used in veterinary medicine for similar purposes.

Levetiracetam is sometimes used off-label to treat status epilepticus or to prevent seizures associated with subarachnoid hemorrhages.

Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome,anxiety disorder,and Alzheimer’s disease.However, its most serious adverse effects are behavioral, and its benefit-risk ratio in these conditions is not well understood.

Levetiracetam has not been found to be useful for treatment of neuropathic pain,nor for treatment of essential tremors.Levetiracetam has not been found to be useful for treating autism, but is an effective treatment for partial, myoclonic, or tonic-clonic seizures associated with autism spectrum disorder.

 

 

99% Raw Brivaracetam Powder

Molecular Formula:C11H20N2O2
Formula Weight:212.29
CAS No.:357336-20-0
Appearance:white powder
Purity:99%

Brivaracetam is a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties.

Brivaracetam is used to treat partial-onset seizures with or without secondary generalisation, in combination with other antiepileptic drugs. No data are available for its effectiveness and safety in patients younger than 16 years.